An update on interventional cardiology: management of CTO, performance of absorbable scaffolds, coronary vasomotion after DES, and antithrombotics.
Editor-in-Chief, Zurich Heart House, Careum Campus, Moussonstrasse 4, 8091 Zurich, Switzerland.
Thomas F
TF
Lüscher
D020341:Absorbable Implants; D000933:Antifibrinolytic Agents / Q000627:therapeutic use*; D017023:Coronary Angiography; D054059:Coronary Occlusion / Q000628:therapy*; D054855:Drug-Eluting Stents / Q000009:adverse effects; D006801:Humans; D062645:Percutaneous Coronary Intervention / Q000379:methods; D011474:Prosthesis Design; D054457:Tissue Scaffolds; D016896:Treatment Outcome
D000933:Antifibrinolytic Agents